drugset / Trial / NCT00748046
Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton
NaSingle-groupOpen-labelBasic science
Summary
The purpose of the study is to investigate the safety, biodistribution, radiation dosimetry and pharmacokinetics of three intravenous escalating dose levels of Xofigo (Alpharadin).
Timeline
- Start
- 2008-08
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Radium-223 dichloride | Other / unclassified | 0.05 mbq/kg | — |
| Subject | Radium-223 dichloride | Other / unclassified | 0.1 mbq/kg | — |
| Subject | Radium-223 dichloride | Other / unclassified | 0.2 mbq/kg | — |